Screener
BioRestorative Therapies BRTX Q1 2026 earnings
Reported May 14, 2026 · Before market open
Revenue$23.2KMiss by $289.3K
EPS-$0.19Beat by $0.01
Revenue estimate$312.5K
EPS estimate-$0.20
Next report
Sep 22, 2026 (In 4 days)Revenue estimate$600.0K
EPS estimate-$2.00
Versus estimates
Revenue
Diluted EPS
FAQ
- When did BioRestorative Therapies report Q1 2026 earnings?
- BioRestorative Therapies (BRTX) reported Q1 2026 earnings on May 14, 2026 before market open.
- What were BioRestorative Therapies's Q1 2026 revenue and EPS?
- BioRestorative Therapies reported revenue of $23.2K and eps of $-0.19 for Q1 2026.
- Did BioRestorative Therapies beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $312.5K by $289.3K. EPS beat the consensus estimate of $-0.20 by $0.01.
- How did BioRestorative Therapies's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 7.3% from $25.0K a year earlier and eps grew 66.1% from $-0.56.
- Where can I find BioRestorative Therapies's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001493152-26-023126) directly on SEC EDGAR. The filing index links above go to sec.gov.
